3.
Comparison of median survival of CRS+HIPEC versus surgery alone
| Treatment | Case No. (Ref No.) | Median survival (month) | P |
| CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy. | |||
| CRS+HIPEC | 34 (19) | 11.0 | 0.046 |
| 17 (24) | 11.0 | 0.0455 | |
| 107 (25) | 11.5 | 0.001 | |
| 49 (26) | 10.3 | Not provided | |
| Surgery alone | 34 (19) | 6.5 | 0.046 |
| 20 (24) | 6.0 | 0.0455 | |